Sustainability | July 20, 2022
Essential Pharma progress in its ESG performance
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
She joins Enveda from Gilead Sciences
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
Subscribe To Our Newsletter & Stay Updated
